Ocular Therapeutix™ to Participate in Upcoming Scientific Conferences
Provided By GlobeNewswire
Last update: Oct 7, 2025
BEDFORD, Mass., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming scientific conferences in October 2025.
Read more at globenewswire.com
